KR100987534B1 - 식욕감퇴 방향제 조성물 - Google Patents
식욕감퇴 방향제 조성물 Download PDFInfo
- Publication number
- KR100987534B1 KR100987534B1 KR1020100083183A KR20100083183A KR100987534B1 KR 100987534 B1 KR100987534 B1 KR 100987534B1 KR 1020100083183 A KR1020100083183 A KR 1020100083183A KR 20100083183 A KR20100083183 A KR 20100083183A KR 100987534 B1 KR100987534 B1 KR 100987534B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- appetite
- weight
- fragrance
- parts
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 90
- 230000036528 appetite Effects 0.000 title claims abstract description 61
- 235000019789 appetite Nutrition 0.000 title claims abstract description 61
- 230000007423 decrease Effects 0.000 title abstract description 10
- 125000003118 aryl group Chemical group 0.000 title description 3
- 239000003205 fragrance Substances 0.000 claims abstract description 85
- 239000002304 perfume Substances 0.000 claims abstract description 36
- 239000000284 extract Substances 0.000 claims description 93
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- 240000002045 Guettarda speciosa Species 0.000 claims description 14
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 14
- 239000002781 deodorant agent Substances 0.000 claims description 10
- 229940069445 licorice extract Drugs 0.000 claims description 8
- 229940002508 ginger extract Drugs 0.000 claims description 7
- 235000020708 ginger extract Nutrition 0.000 claims description 7
- 235000020737 peppermint extract Nutrition 0.000 claims description 7
- 230000004596 appetite loss Effects 0.000 claims description 5
- 229940052200 mold extract Drugs 0.000 claims description 5
- 244000111489 Gardenia augusta Species 0.000 claims 2
- 244000299790 Rheum rhabarbarum Species 0.000 claims 2
- 229940027779 persimmon extract Drugs 0.000 claims 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 32
- 238000000194 supercritical-fluid extraction Methods 0.000 abstract description 6
- 238000001035 drying Methods 0.000 abstract description 3
- 239000012530 fluid Substances 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 42
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 34
- 239000000341 volatile oil Substances 0.000 description 22
- 241000219061 Rheum Species 0.000 description 21
- 230000009467 reduction Effects 0.000 description 21
- 241000411851 herbal medicine Species 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 19
- 229910002092 carbon dioxide Inorganic materials 0.000 description 17
- 239000001569 carbon dioxide Substances 0.000 description 17
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 15
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 15
- 229940010454 licorice Drugs 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 235000005911 diet Nutrition 0.000 description 12
- 230000037213 diet Effects 0.000 description 12
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 11
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 11
- 241000157835 Gardenia Species 0.000 description 10
- 208000008589 Obesity Diseases 0.000 description 10
- 235000020824 obesity Nutrition 0.000 description 10
- 244000246386 Mentha pulegium Species 0.000 description 9
- 235000016257 Mentha pulegium Nutrition 0.000 description 9
- 235000004357 Mentha x piperita Nutrition 0.000 description 9
- 206010061428 decreased appetite Diseases 0.000 description 9
- 235000001050 hortel pimenta Nutrition 0.000 description 9
- 229940039781 leptin Drugs 0.000 description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 description 8
- 102000016267 Leptin Human genes 0.000 description 8
- 108010092277 Leptin Proteins 0.000 description 8
- 235000006886 Zingiber officinale Nutrition 0.000 description 8
- 235000008397 ginger Nutrition 0.000 description 8
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 8
- 241000202807 Glycyrrhiza Species 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000006403 short-term memory Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- KJDSORYAHBAGPP-UHFFFAOYSA-N 4-(3,4-diaminophenyl)benzene-1,2-diamine;hydron;tetrachloride Chemical compound Cl.Cl.Cl.Cl.C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 KJDSORYAHBAGPP-UHFFFAOYSA-N 0.000 description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 description 4
- 235000002899 Mentha suaveolens Nutrition 0.000 description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 241000234314 Zingiber Species 0.000 description 4
- 244000273928 Zingiber officinale Species 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000003880 negative regulation of appetite Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 229930040373 Paraformaldehyde Natural products 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000003364 immunohistochemistry Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000015654 memory Effects 0.000 description 3
- 229920002866 paraformaldehyde Polymers 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001378 electrochemiluminescence detection Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 210000003016 hypothalamus Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000060234 Gmelina philippensis Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000013542 behavioral therapy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000011302 passive avoidance test Methods 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Polymers & Plastics (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2010/006119 WO2011059171A2 (fr) | 2009-11-12 | 2010-09-09 | Composition pour agent aromatique coupe-faim |
| JP2012538745A JP5565917B2 (ja) | 2009-11-12 | 2010-09-09 | 食欲減退芳香剤組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20090109210 | 2009-11-12 | ||
| KR1020090109210 | 2009-11-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR100987534B1 true KR100987534B1 (ko) | 2010-10-12 |
Family
ID=43135406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020100083183A KR100987534B1 (ko) | 2009-11-12 | 2010-08-26 | 식욕감퇴 방향제 조성물 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP5565917B2 (fr) |
| KR (1) | KR100987534B1 (fr) |
| WO (1) | WO2011059171A2 (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101486041B1 (ko) * | 2014-03-31 | 2015-01-23 | 주식회사 자연인 | 기억력 증진 한방 방향제 조성물 |
| KR101538417B1 (ko) * | 2012-04-27 | 2015-07-22 | (주)힐링네이처농업회사법인 | 천궁 정유 조성물과 이를 함유하는 향장품 |
| CN106362185A (zh) * | 2016-09-28 | 2017-02-01 | 天承南运(天津)科技有限公司 | 一种清新醒神香囊及其制备方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579643A (zh) * | 2012-02-27 | 2012-07-18 | 苏州爱斯欧蒂生物科技有限公司 | 新型高效减肥药 |
| JP6758799B2 (ja) * | 2014-09-30 | 2020-09-23 | 小林製薬株式会社 | 医薬組成物 |
| WO2016057336A1 (fr) * | 2014-10-06 | 2016-04-14 | Jb Scientific, Llc | Systèmes, appareils et procédés pour délivrer une séquence d'odeurs dans le but de modifier l'appétit d'un individu |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070008177A (ko) * | 2005-07-13 | 2007-01-17 | 정기석 | 식욕억제 및 체중감소 조성물을 함유하는 아로마 향수 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR19990079304A (ko) * | 1998-04-03 | 1999-11-05 | 이선향 | 한약 방향제의 제조방법 |
| KR20040062832A (ko) * | 2003-01-03 | 2004-07-09 | 학교법인 경희대학교 | 비만 치료 또는 예방용 및, 비만과 관련된 유전자,단백질, 세포 발현 조절용 한약 추출물을 포함하는약제학적 조성물 |
| KR100509397B1 (ko) * | 2003-06-23 | 2005-08-18 | 배근희 | 약초 방향제 조성물 |
| JP2009051770A (ja) * | 2007-08-27 | 2009-03-12 | Takasago Internatl Corp | 食欲抑制用組成物 |
-
2010
- 2010-08-26 KR KR1020100083183A patent/KR100987534B1/ko active IP Right Grant
- 2010-09-09 JP JP2012538745A patent/JP5565917B2/ja active Active
- 2010-09-09 WO PCT/KR2010/006119 patent/WO2011059171A2/fr active Application Filing
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070008177A (ko) * | 2005-07-13 | 2007-01-17 | 정기석 | 식욕억제 및 체중감소 조성물을 함유하는 아로마 향수 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101538417B1 (ko) * | 2012-04-27 | 2015-07-22 | (주)힐링네이처농업회사법인 | 천궁 정유 조성물과 이를 함유하는 향장품 |
| KR101486041B1 (ko) * | 2014-03-31 | 2015-01-23 | 주식회사 자연인 | 기억력 증진 한방 방향제 조성물 |
| CN106362185A (zh) * | 2016-09-28 | 2017-02-01 | 天承南运(天津)科技有限公司 | 一种清新醒神香囊及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013510847A (ja) | 2013-03-28 |
| WO2011059171A2 (fr) | 2011-05-19 |
| WO2011059171A3 (fr) | 2011-07-14 |
| JP5565917B2 (ja) | 2014-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100987534B1 (ko) | 식욕감퇴 방향제 조성물 | |
| CN104257597A (zh) | 一种石斛美容液及其制备方法 | |
| JP4889954B2 (ja) | 女性ホルモン調節機能調整用香料組成物 | |
| CN103040713B (zh) | 一种防治脂溢性脱发、头痒的中药洗发膏 | |
| JP4805589B2 (ja) | エストロゲン様作用剤 | |
| CN110327438A (zh) | 一种舒缓按摩膏 | |
| CN106074239A (zh) | 一种金银花面膜精华液及制备方法 | |
| KR101184184B1 (ko) | 발모촉진제 및 그 제조방법 | |
| CN103446247A (zh) | 一种防止肌肤衰老的高渗透力复方精油 | |
| KR20100022137A (ko) | 녹용을 포함하는 발효 한방 생약 추출물을 함유한 탈모방지용 화장품 샴푸 제조방법 및 샴푸 | |
| CN109248117A (zh) | 含菠萝蛋白酶、假叶树、葡萄籽、山金车和香蜂草的化妆品组合物 | |
| CN108853356A (zh) | 一种男士延时喷剂及其制备方法 | |
| CN106259533A (zh) | 驱蚊组合物及由驱蚊组合物制成的驱蚊包及其驱蚊包的使用方法 | |
| KR101001867B1 (ko) | 사이프러스 에센셜 복합 오일을 유효 성분으로 함유하는 기억력 증진 및 인지 기능 장애 개선을 위한 화장료 조성물 | |
| KR102152752B1 (ko) | 구상나무 추출물을 포함하는 스트레스 완화 및 심리적 안정 증진용 향료 조성물 | |
| KR20170126590A (ko) | 두피열해소기능을 갖는 발모촉진조성물 및 그 제조방법 | |
| KR20190122306A (ko) | 탈모 방지 및 발모 촉진용 조성물 | |
| CN105213279A (zh) | 一种消除萎缩纹的身体乳及其制备方法 | |
| CN105106068A (zh) | 安神香水 | |
| CN110381971A (zh) | 女性更年期症状改善用组合物 | |
| CN104922008A (zh) | 一种除色斑精华素 | |
| JP2008247894A (ja) | ストレス応答力改善剤 | |
| KR101971574B1 (ko) | 윈터체리뿌리, 산뽕나무 및 보이차 추출물을 포함하는 수면 장애 개선 또는 숙면 유지용 화장료 조성물 | |
| CN104689292A (zh) | 兼具提神及杀菌消毒功效的复方精油 | |
| Sandanshiv et al. | Formulation and Evaluation of Herbal Face Pack |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| A302 | Request for accelerated examination | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20131002 Year of fee payment: 4 |
|
| FPAY | Annual fee payment |
Payment date: 20160923 Year of fee payment: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20170925 Year of fee payment: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20180927 Year of fee payment: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20191020 Year of fee payment: 10 |